A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
2023-11-28 06:27
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
You Might Like...
Software firm Cloudsmith announces £8.8m investment
Nextlink Delivers High-Speed Internet to 95% of Wise County, Texas in 7 months
Munger Became a Legendary Investor Because of This One Impeccable Skill
Iraq to unblock Telegram app as platform responded to security requirements -statement
Biden calls on US colleges to consider adversity during admission process
Broadband customers face £150 hikes because of ‘outrageous’ rises – Which?
Canada bans WeChat, Kaspersky applications on government devices
Amazon to launch online shopping service in South Africa in 2024